Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Recurrence Rate ◽

Real World ◽

Faculty Opinions recommendation of Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1112156.568142 ◽

2008 ◽

Author(s):

Dieter Juengst

Keyword(s):

Chronic Hepatitis ◽

Risk Factor ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Independent Risk Factor ◽

Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies

European Journal of Clinical Microbiology & Infectious Diseases ◽

10.1007/s10096-016-2576-1 ◽

2016 ◽

Vol 35 (4) ◽

pp. 597-609 ◽

Cited By ~ 1

Author(s):

P. Marotta ◽

R. Bailey ◽

M. Elkashab ◽

J. Farley ◽

S. V. Feinman ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Treatment Naïve ◽

Chronic Hepatitis C Patients ◽

Peginterferon Α

The Dynamics of Cytokine Profiles Predicts Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients with Advanced Fibrosis Following Successful Antiviral Therapy

SSRN Electronic Journal ◽

10.2139/ssrn.3752652 ◽

2020 ◽

Author(s):

Ming-Ying Lu ◽

Ming-Lun Yeh ◽

Ching-I Huang ◽

Shu-Chi Wang ◽

Yi-Shan Tsai ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Antiviral Therapy ◽

Chronic Hepatitis C ◽

Advanced Fibrosis ◽

Cytokine Profiles ◽

Effect of Advanced Fibrosis Presence on Adherence to Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients with Sustained Virologic Response

Viral Hepatitis Journal ◽

10.4274/vhd.galenos.2020.2020.0002 ◽

2020 ◽

Vol 26 (1) ◽

pp. 32-38

Author(s):

Göktuğ Şirin ◽

Sadettin Hülagü

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Sustained Virologic Response ◽

Virologic Response ◽

Advanced Fibrosis ◽

Hepatocellular Carcinoma Surveillance ◽

Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients

Pathology & Oncology Research ◽

10.1007/s12253-019-00738-6 ◽

2019 ◽

Vol 26 (3) ◽

pp. 1519-1525

Author(s):

Camila Guerra Marangon ◽

Jóice Teixeira de Bitencorte ◽

Rafael Tomoya Michita ◽

Vagner Ricardo Lunge ◽

Deivid Cruz dos Santos ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients

Liver International ◽

10.1111/liv.12118 ◽

2013 ◽

Vol 33 (5) ◽

pp. 756-761 ◽

Cited By ~ 35

Author(s):

Hsin-Ming Wang ◽

Chao-Hung Hung ◽

Sheng-Nan Lu ◽

Chien-Hung Chen ◽

Chuan-Mo Lee ◽

...

Keyword(s):

Risk Assessment ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Liver Stiffness ◽

Liver Stiffness Measurement ◽

Stiffness Measurement ◽

Aspartate Aminotransferase-to-Platelet Ratio or Fibros-4 Index Predicts the Development of Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Sustained Virologic Response to Interferon Therapy

Journal of Interferon & Cytokine Research ◽

10.1089/jir.2019.0049 ◽

2019 ◽

Vol 39 (11) ◽

pp. 703-710 ◽

Cited By ~ 1

Author(s):

Seong Kyun Na ◽

Soon Jae Lee ◽

Yoo-Kyung Cho ◽

Young Nam Kim ◽

Eun Kwang Choi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Aspartate Aminotransferase ◽

Sustained Virologic Response ◽

Interferon Therapy ◽

Virologic Response ◽

Real‐world effectiveness of direct‐acting antiviral agents for chronic hepatitis C patients with genotype‐2 infection after completed treatment

The Kaohsiung Journal of Medical Sciences ◽

10.1002/kjm2.12315 ◽

2020 ◽

Author(s):

Tzu‐Sheng Cheng ◽

Po‐Cheng Liang ◽

Chung‐Feng Huang ◽

Ming‐Lun Yeh ◽

Ching‐I Huang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Antiviral Agents ◽

Direct Acting Antiviral ◽

Genotype 2 ◽

Direct Acting ◽

Chronic Hepatitis C Patients ◽

Direct Acting Antiviral Agents

GS-03-Global real world evidence of sofosbuvir/velpatasvir as a simple, effective regimen for the treatment of chronic hepatitis C patients: Integrated analysis of 12 clinical practice cohorts

Journal of Hepatology ◽

10.1016/s0618-8278(19)30003-9 ◽

2019 ◽

Vol 70 (1) ◽

pp. e2-e3 ◽

Cited By ~ 4

Author(s):

Alessandra Mangia ◽

Scott Milligan ◽

Mandana Khalili ◽

Stefano Fagiuoli ◽

Stephen Shafran ◽

...

Keyword(s):

Chronic Hepatitis ◽

Clinical Practice ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽

Integrated Analysis ◽

Effective Regimen ◽

Real World Evidence ◽

Real‐world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.14845 ◽

2019 ◽

Vol 35 (3) ◽

pp. 467-472 ◽

Cited By ~ 3

Author(s):

Jyh‐Jou Chen ◽

Pei‐Lun Lee ◽

Hung‐Chih Chiu ◽

Hung‐Da Tung ◽

Yen‐Cheng Chiu ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Real World ◽